Wayland Group WKN: A2PAPZ ISIN: CA9442041062 Kürzel: MRRCF Forum: Aktien Thema: Hauptdiskussion

Septon was heist endgültig gibt es schon ne Richtung wo es hingehen wird!?!

Ja stinkt ... Börse ist nur noch für ma.fia

Schau Volumen da steigen welche gross ein ... Preis stinkt

Ja @Trader

Der ganze grüne Sektor korrigiert sich auf Beginn der letzten Woche zurück. Wenn es wieder wie letzte Woche läuft zum Ende läuft es doch perfekt

Drücken ohne Stress, Kaufen zu Preisen die sie wollen. Der kleine zahlt immer.

Scheiss Bonzen

Am 07. Dezember 2018 kommt der endgültige Entscheid von der WHO, ob Cannabis von der Drogenliste genommen wird oder nicht. Quelle: do-tank-en/ecdd41-press-release/ (googlen)

@Gemini: danke fürs Vid. Ist ne gute Investorpräsentation. Ben macht das gut. Reden kann er. Macht nen recht sicheren Eindruck.

Und weiter geht's.... Bomben News.

Aber sowas von Bomben news... gb braucht für Freizeitkonsum glaub ich nicht mehr all zu lange !

Wayland Group Enters the United Kingdom By GlobeNewswire,  November 26, 2018, 01:30:00 AM EDT Vote up AAA TORONTO, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) ("Wayland" or the "Company") is pleased to announce it has entered into an agreement to acquire 51% of UK based Theros Pharma Ltd. ("Theros"), an early stage company that has successfully imported cannabis to the UK for patients with a prescription for medical cannabis. This transaction enhances Wayland's global growth strategy and will provide the Company with access to the UK market for sale and distribution of its products. Recent UK legislation allows for the prescription of cannabis from a medical specialist via a regular pharmacy model. Access to this burgeoning market, with National Health Service insurance coverage for medical cannabis to ensure patient outcomes, is a key strategic element of Wayland's global platform. "We're proud to join with Theros on the journey to enhance lives through cannabis, now in the UK. Theros' dedicated team of professionals and advocates, who were instrumental in achieving cannabis legalization in the UK will work with Wayland to create access to cannabis for patients and further advocate for personalized medicine," Declared Wayland Chief Executive Officer Ben Ward. "I am very pleased that Wayland is working with Theros, to bring good quality medical cannabis into the UK. I hope this supply will bring benefit to many thousands of people in the UK who deserve a chance to use this medication to alleviate so many disabling symptoms," stated Hannah Deacon, mother of Alfie Dingley who received the first medical UK cannabis license. Professor Mike Barnes, neurologist and medical cannabis campaigner who helped to obtain the first UK license for Alfie said, "It will be a pleasure to work in collaboration with Wayland. I look forward to a fruitful partnership so that medical cannabis can be brought to so many people who deserve it." Pursuant to the terms of the agreement the Company has agreed to make an initial payment of 3,800,000GBP followed by a second payment of 24,000,000GBP following certain milestones being achieved, including issuance to Theros of a license to cultivate cannabis in the UK or a license to import medical cannabis for use in the UK. Both payments will be satisfied by the issuance of common shares of the Company based on then-current market prices, but subject to a floor issue price of $1.65 per Common Share. The payments are conditional on receipt of applicable stock exchange approval, approval of holders of at least two-thirds of the Company's outstanding debentures and any other applicable approvals.  Maricann Group Inc., through its subsidiaries, is operating under the Wayland Group name. For further details see the press release dated September 24, 2018. About Wayland Group

So fängt der Tag doch gut an!

Maschine!!!

News!

29.11.abwarten q3 Zahlen